Hepatitis D screening: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Screening== | ==Screening== | ||
All patients with current or previous IV drug use history should be evaluated for hepatitis B. However, screening is not recommended in asymptomatic HBsAg positive patients. The following preventive and screening may be applied: | All patients with current or previous IV drug use history should be evaluated for hepatitis B. However, screening is not recommended in asymptomatic HBsAg positive patients. The following preventive and screening may be applied in: | ||
*HBsAg positive patients, who have acute or chronic hepatitis D. | *HBsAg positive patients, who have acute or chronic hepatitis D. The follow-up procedures should be equal, regardless of co-infection status with hepatitis D | ||
* | |||
<!-- | <!-- | ||
* | * The followup care and counseling, however, of a person co-infected with hepatitis D is not different from that of a person who is HBsAg positive. Therefore, knowing if the patient is co-infected with hepatitis D is of limited clinical significance. | ||
* Patients with acute hepatitis B who are not yet HBsAg positive, but are immunoglobulin M (IgM) hepatitis B core antibody (anti-HBc) positive, may be tested for HDV; however, again, the presence of HDV antibody will not alter the care or counseling of such a patient | * Patients with acute hepatitis B who are not yet HBsAg positive, but are immunoglobulin M (IgM) hepatitis B core antibody (anti-HBc) positive, may be tested for HDV; however, again, the presence of HDV antibody will not alter the care or counseling of such a patient | ||
Revision as of 03:01, 6 August 2014
|
Hepatitis D |
|
Diagnosis |
|
Treatment |
|
Hepatitis D screening On the Web |
|
American Roentgen Ray Society Images of Hepatitis D screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Varun Kumar, M.B.B.S. [2]
Overview
Screening
All patients with current or previous IV drug use history should be evaluated for hepatitis B. However, screening is not recommended in asymptomatic HBsAg positive patients. The following preventive and screening may be applied in:
- HBsAg positive patients, who have acute or chronic hepatitis D. The follow-up procedures should be equal, regardless of co-infection status with hepatitis D